Bu öğeden alıntı yapmak, öğeye bağlanmak için bu tanımlayıcıyı kullanınız: http://hdl.handle.net/11452/24297
Başlık: The potential relationship between QTc interval prolongation and ziprasidone treatment: Three cases
Yazarlar: Uludağ Üniversitesi/Tıp Fakültesi/Psikiyatri Anabilim Dalı.
Eker, Salih Saygın
Sarandol, Aslı
Akkaya, Cengiz
Sivrioğlu, Enver Yusuf
Kırlı, Selçuk
Q-9477-2019
14019347700
14020405100
14061855100
14062563200
14019745700
Anahtar kelimeler: Antipsychotic
QTc prolongation
Ziprasidone
Torsade-de-pointes
Schizoaffective disorder
Antipsychotic-drugs
Acute exacerbation
Double-blind
160 mg/day
Schizophrenia
Safety
Haloperidol
Management
Neurosciences & neurology
Pharmacology & pharmacy
Psychiatry
Yayın Tarihi: Kas-2009
Yayıncı: Sage Publications
Atıf: Eker, S. S. vd. (2009). "The potential relationship between QTc interval prolongation and ziprasidone treatment: Three cases". Journal of Psychopharmacology, 23(8), 993-996.
Özet: QTc interval prolongation may appear as a consequence of both typical and atypical antipsychotic treatments. Ziprasidone, which is effective in treating schizophrenia, is associated with QTc prolongation. Although the prolongation of QTc with ziprasidone treatment is often pronounced, there is a scarce number of cases reported about the relationship between ziprasidone and QTc prolongation. Of the three cases presented in this case series, two cases showed values exceeding 0.50 s with ziprasidone treatment.
URI: https://doi.org/10.1177/0269881108093843
https://journals.sagepub.com/doi/10.1177/0269881108093843
http://hdl.handle.net/11452/24297
ISSN: 0269-8811
Koleksiyonlarda Görünür:Scopus
Web of Science

Bu öğenin dosyaları:
Bu öğeyle ilişkili dosya bulunmamaktadır.


DSpace'deki bütün öğeler, aksi belirtilmedikçe, tüm hakları saklı tutulmak şartıyla telif hakkı ile korunmaktadır.